Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Development and prevention of morphologic and ultrastructural changes in uremia-induced hyperplastic parathyroid gland.

Shiizaki K, Hatamura I, Mato M, Nakazawa E, Saji F, Onishi A, Ogura M, Watanabe Y, Kusano E.

Ultrastruct Pathol. 2011 Oct;35(5):230-8. doi: 10.3109/01913123.2011.601406. Epub 2011 Aug 25.

PMID:
21867406
2.

MafB interacts with Gcm2 and regulates parathyroid hormone expression and parathyroid development.

Kamitani-Kawamoto A, Hamada M, Moriguchi T, Miyai M, Saji F, Hatamura I, Nishikawa K, Takayanagi H, Hitoshi S, Ikenaka K, Hosoya T, Hotta Y, Takahashi S, Kataoka K.

J Bone Miner Res. 2011 Oct;26(10):2463-72. doi: 10.1002/jbmr.458.

3.

Calcium oxalate crystal deposition in metabolic syndrome model rat kidneys.

Okamoto M, Kohjimoto Y, Iba A, Saji F, Hara I, Shigematsu T.

Int J Urol. 2010 Dec;17(12):996-1003. doi: 10.1111/j.1442-2042.2010.02661.x.

4.

Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.

Saji F, Shigematsu T, Sakaguchi T, Ohya M, Orita H, Maeda Y, Ooura M, Mima T, Negi S.

Am J Physiol Renal Physiol. 2010 Nov;299(5):F1212-7. doi: 10.1152/ajprenal.00169.2010. Epub 2010 Aug 25.

5.

Development of a technique for introduction of an expressed complementary deoxyribonucleic acid into parathyroid cells by direct injection.

Shiizaki K, Hatamura I, Fukagawa M, Nakazawa E, Saji F, Watanabe Y, Akizawa T, Kusano E.

Endocrinology. 2010 Aug;151(8):4031-8. doi: 10.1210/en.2010-0012. Epub 2010 Jun 2.

PMID:
20519369
6.

Reduced expression of perlecan in the aorta of secondary hyperparathyroidism model rats with medial calcification.

Shibata M, Shigematsu T, Hatamura I, Saji F, Mune S, Kunimoto K, Hanba Y, Shiizaki K, Sakaguchi T, Negi S.

Ren Fail. 2010 Jan;32(2):214-23. doi: 10.3109/08860220903367544.

PMID:
20199184
7.

Mechanism of phosphate-induced calcification in rat aortic tissue culture: possible involvement of Pit-1 and apoptosis.

Mune S, Shibata M, Hatamura I, Saji F, Okada T, Maeda Y, Sakaguchi T, Negi S, Shigematsu T.

Clin Exp Nephrol. 2009 Dec;13(6):571-7. doi: 10.1007/s10157-009-0208-0. Epub 2009 Aug 5.

PMID:
19655218
8.

Improvement of impaired calcium and skeletal homeostasis in vitamin D receptor knockout mice by a high dose of calcitriol and maxacalcitol.

Shiizaki K, Hatamura I, Imazeki I, Moriguchi Y, Sakaguchi T, Saji F, Nakazawa E, Kato S, Akizawa T, Kusano E.

Bone. 2009 Nov;45(5):964-71. doi: 10.1016/j.bone.2009.07.013. Epub 2009 Jul 23.

PMID:
19631778
9.

Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.

Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T.

Clin Exp Nephrol. 2009 Oct;13(5):438-446. doi: 10.1007/s10157-009-0196-0. Epub 2009 May 19.

PMID:
19452240
10.

Regulation of fibroblast growth factor 23 production in bone in uremic rats.

Saji F, Shiizaki K, Shimada S, Okada T, Kunimoto K, Sakaguchi T, Hatamura I, Shigematsu T.

Nephron Physiol. 2009;111(4):p59-66. doi: 10.1159/000210389. Epub 2009 Apr 1.

PMID:
19339809
11.

Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study.

Yamamoto K, Kokawa K, Umesaki N, Nishimura R, Hasegawa K, Konishi I, Saji F, Nishida M, Noguchi H, Takizawa K.

Oncol Rep. 2009 Apr;21(4):1005-9.

PMID:
19288001
12.

Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats.

Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Imazeki I, Kusano E, Shigematsu T, Akizawa T.

Nephrol Dial Transplant. 2008 May;23(5):1529-36. Epub 2007 Dec 21.

PMID:
18156462
13.

Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia.

Shiizaki K, Fukagawa M, Yuan Q, Hatamura I, Nii-Kono T, Saji F, Shigematsu T, Akizawa T.

Am J Nephrol. 2008;28(1):59-66. Epub 2007 Sep 28.

PMID:
17901691
14.

Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells.

Mizobuchi M, Ogata H, Hatamura I, Saji F, Koiwa F, Kinugasa E, Koshikawa S, Akizawa T.

Biochem Biophys Res Commun. 2007 Oct 12;362(1):11-16. doi: 10.1016/j.bbrc.2007.07.177. Epub 2007 Aug 9.

PMID:
17706605
15.

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.

Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T, Hatae M, Kodama S, Saito T, Terakawa N, Yaegashi N, Hiura M, Sakamoto A, Tsuda H, Fukunaga M, Kamura T.

J Clin Oncol. 2007 Jul 1;25(19):2798-803.

PMID:
17602085
16.

Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.

Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Kunimoto K, Okamoto M, Imazeki I, Muragaki Y, Akizawa T.

Kidney Int. 2006 Aug;70(3):486-95. Epub 2006 Jun 21.

17.

Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma.

Kinugasa Y, Morishige K, Kamiura S, Tsukamoto Y, Saji F.

Jpn J Clin Oncol. 2006 Feb;36(2):113-5. Epub 2006 Jan 17.

PMID:
16418186
18.

[Enhanced expression of EGFR, TGF-alpha, EGF in hyperplastic parathyroid glands in established stage of renal failure in rats].

Orita H, Hatamura I, Saji F, Shibata M, Shiizaki K, Sakaguchi T, Negi S, Akizawa T.

Clin Calcium. 2005 Sep;15 Suppl 1:60-63; discussion 63. Japanese. Erratum in: Clin Calcium.2006 Feb;16(2):149-52.

PMID:
16411340
19.

Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism.

Mizobuchi M, Ogata H, Hatamura I, Koiwa F, Saji F, Shiizaki K, Negi S, Kinugasa E, Ooshima A, Koshikawa S, Akizawa T.

Nephrol Dial Transplant. 2006 Apr;21(4):911-6. Epub 2005 Dec 29.

PMID:
16384827
20.

MR imaging evaluation of postmenopausal adnexal masses: correlation with final pathologic diagnosis.

Temma-Asano K, Kimura T, Tsutsui T, Nobunaga T, Samejima Y, Mitsuda N, Kameda T, Ohta Y, Yamamoto T, Saji F, Kamiura S.

Maturitas. 2006 Jan 10;53(1):27-31.

PMID:
16325021
21.

[Apoptosis: a possible mechanism of suppressing parathyroid hyperplasia by calcimimetics].

Mizobuchi M, Saji F, Shiizaki K, Sato T, Shibata M, Negi S, Akizawa T, Hatamura I, Ogata H, Kinugasa E.

Clin Calcium. 2005 Sep;15 Suppl 1:56-8; discussion 58-9. Japanese. Erratum in: Clin Calcium. 2006 Feb;16(2):149-52.

PMID:
16272631
22.

[A dose escalation study of concurrent chemoradiation therapy with nedaplatin for cervical cancer].

Hatae M, Takahashi T, Kodama S, Nakayama H, Kuzuya K, Saji F, Kamiura S, Watanabe Y, Nishimura R, Kono I, Ariyosh Y, Fukuoka M, Imajo Y, Hasegawa K, Noda K; Efficacy and; Safety Assessment Committee.

Gan To Kagaku Ryoho. 2005 Apr;32(4):473-8. Japanese.

PMID:
15853213
23.

Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.

Shiizaki K, Negi S, Hatamura I, Sakaguchi T, Saji F, Kunimoto K, Mizobuchi M, Imazeki I, Ooshima A, Akizawa T.

J Am Soc Nephrol. 2005 Jan;16(1):97-108. Epub 2004 Dec 1.

24.

[Combination chemotherapy with nedaplatin and paclitaxel for ovarian cancer].

Yamamoto T, Morishige K, Ohta Y, Kamiura S, Saji F.

Nihon Rinsho. 2004 Oct;62 Suppl 10:550-3. Japanese. No abstract available.

PMID:
15535306
25.

Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.

Mizobuchi M, Hatamura I, Ogata H, Saji F, Uda S, Shiizaki K, Sakaguchi T, Negi S, Kinugasa E, Koshikawa S, Akizawa T.

J Am Soc Nephrol. 2004 Oct;15(10):2579-87.

26.

Abnormal uterine bleeding and prognosis of endometrial cancer.

Kimura T, Kamiura S, Yamamoto T, Seino-Noda H, Ohira H, Saji F.

Int J Gynaecol Obstet. 2004 May;85(2):145-50.

PMID:
15099776
27.
28.

Metastatic ovarian tumors: a review of 64 cases.

Yada-Hashimoto N, Yamamoto T, Kamiura S, Seino H, Ohira H, Sawai K, Kimura T, Saji F.

Gynecol Oncol. 2003 May;89(2):314-7. Review.

PMID:
12713997
29.

Molecular regulation of the oxytocin receptor in peripheral organs.

Kimura T, Saji F, Nishimori K, Ogita K, Nakamura H, Koyama M, Murata Y.

J Mol Endocrinol. 2003 Apr;30(2):109-15. Review.

PMID:
12683935
30.

Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer.

Sugiyama T, Yakushiji M, Kamura T, Ikeda M, Umesaki N, Hasegawa K, Ishikawa M, Saji F, Hiura M, Takahashi T, Sato S, Ochiai K, Kikkawa F, Takeuchi S, Ohashi Y, Noda K; Japan CPT-11 Study Group.

Oncology. 2002;63(1):16-22.

PMID:
12187066
31.

Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in cervical intraepithelial neoplasia.

Isaka S, Sawai K, Tomiie M, Kamiura S, Koyama M, Azuma C, Ishiguro S, Murata Y, Saji F.

Int J Oncol. 2002 Aug;21(2):281-7.

PMID:
12118322
32.

[Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].

Kamiura S, Kobayashi K, Ohira H, Seino H, Hashimoto N, Sawai K, Samejima Y, Saji F.

Gan To Kagaku Ryoho. 2001 Jul;28(7):979-86. Japanese.

PMID:
11478148
33.

beta(2)-adrenergic agonists and pelvic floor exercises for female stress incontinence.

Ishiko O, Ushiroyama T, Saji F, Mitsuhashi Y, Tamura T, Yamamoto K, Kawamura Y, Ogita S.

Int J Gynaecol Obstet. 2000 Oct;71(1):39-44.

PMID:
11044540
34.

Cytokine production in chorioamnionitis.

Saji F, Samejima Y, Kamiura S, Sawai K, Shimoya K, Kimura T.

J Reprod Immunol. 2000 Jul;47(2):185-96. Review.

PMID:
10924750
35.

Expression of RANTES by IL-1 beta and TNF-alpha stimulated nasal polyp fibroblasts.

Saji F, Nonaka M, Pawankar R.

Auris Nasus Larynx. 2000 Jul;27(3):247-52.

PMID:
10808113
36.

Eotaxin synthesis by nasal polyp fibroblasts.

Nonaka M, Pawankar R, Saji F, Yagi T.

Acta Otolaryngol. 1999;119(7):816-20.

PMID:
10687940
37.

Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer.

Sugiyama T, Yakushiji M, Noda K, Ikeda M, Kudoh R, Yajima A, Tomoda Y, Terashima Y, Takeuchi S, Hiura M, Saji F, Takahashi T, Umesaki N, Sato S, Hatae M, Ohashi Y.

Oncology. 2000;58(1):31-7.

PMID:
10644938
38.

Distinct expression of RANTES and GM-CSF by lipopolysaccharide in human nasal fibroblasts but not in other airway fibroblasts.

Nonaka M, Pawankar R, Saji F, Yagi T.

Int Arch Allergy Immunol. 1999 Aug;119(4):314-21.

PMID:
10474037
39.

Human placental cells show enhanced production of interleukin (IL)-8 in response to lipopolysaccharide (LPS), IL-1 and tumour necrosis factor (TNF)-alpha, but not to IL-6.

Shimoya K, Moriyama A, Matsuzaki N, Ogata I, Koyama M, Azuma C, Saji F, Murata Y.

Mol Hum Reprod. 1999 Sep;5(9):885.

PMID:
10460229
40.

Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle.

Moriyama A, Shimoya K, Ogata I, Kimura T, Nakamura T, Wada H, Ohashi K, Azuma C, Saji F, Murata Y.

Mol Hum Reprod. 1999 Jul;5(7):656-61.

PMID:
10381821
41.

Dynamics of immunoglobulins at the feto-maternal interface.

Saji F, Samejima Y, Kamiura S, Koyama M.

Rev Reprod. 1999 May;4(2):81-9. Review.

PMID:
10357095
42.

Endometrial development was improved by transdermal estradiol in patients treated with clomiphene citrate.

Shimoya K, Tomiyama T, Hashimoto K, Moriyama A, Kawamoto A, Tokugawa Y, Ohashi K, Saji F, Murata Y.

Gynecol Obstet Invest. 1999;47(4):251-4.

PMID:
10352387
43.

Effect of roxithromycin on IL-8 synthesis and proliferation of nasal polyp fibroblasts.

Nonaka M, Pawankar R, Saji F, Yagi T.

Acta Otolaryngol Suppl. 1998;539:71-5.

PMID:
10095866
44.

Suicide gene therapy for human uterine adenocarcinoma cells using herpes simplex virus thymidine kinase.

Kunishige I, Samejima Y, Shiki Y, Moriyama A, Meruelo D, Saji F, Murata Y.

Gynecol Oncol. 1999 Jan;72(1):16-25.

PMID:
9889024
45.

Effect of site directed mutagenesis in the CMGCC region of the alpha-subunit on immunoreactive human thyrotropin.

Miyai K, Kumazawa I, Saji F, Azuma C, Koyama M, Kimura T, Narizuka Y, Kusunoki M, Murata Y.

Endocr J. 1998 Aug;45(4):467-73.

46.

cAMP stimulates the bystander effect in suicide gene therapy of human choriocarcinoma.

Kunishige I, Samejima Y, Moriyama A, Saji F, Murata Y.

Anticancer Res. 1998 Sep-Oct;18(5A):3411-9.

PMID:
9858917
47.

Interaction of a nuclear factor derived from the trophoblast cell line BeWo with the HLA-G gene.

Kimura T, Koyama M, Saji F.

Int J Gynaecol Obstet. 1998 Oct;63(1):67-8. No abstract available.

PMID:
9849716
48.

Secretory leukocyte protease inhibitor (SLP) concentrations in seminal plasma: SLPI restores sperm motility reduced by elastase.

Moriyama A, Shimoya K, Kawamoto A, Hashimoto K, Ogata I, Kunishige I, Ohashi K, Azuma C, Saji F, Murata Y.

Mol Hum Reprod. 1998 Oct;4(10):946-50.

PMID:
9809675
49.

Expression and immunolocalization of the oxytocin receptor in human lactating and non-lactating mammary glands.

Kimura T, Ito Y, Einspanier A, Tohya K, Nobunaga T, Tokugawa Y, Takemura M, Kubota Y, Ivell R, Matsuura N, Saji F, Murata Y.

Hum Reprod. 1998 Sep;13(9):2645-53.

PMID:
9806301
50.

Effect of sexual intercourse on fetal fibronectin concentration in cervicovaginal secretions.

Shimoya K, Hashimoto K, Shimizu T, Saji F, Murata Y.

Am J Obstet Gynecol. 1998 Jul;179(1):255-6.

PMID:
9704795

Supplemental Content

Support Center